Molecular genetic analysis of oligodendroglial tumors for alterations of the CDKN2A and CDKN2B tumor suppressor genes

被引:0
|
作者
Wolter, M
Reifenberger, J
Ichimura, K
Schmidt, EE
Collins, VP
Reifenberger, G
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:570 / 571
页数:2
相关论文
共 50 条
  • [1] Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients
    Kiatprungvech, Nattaradee
    Sangkum, Premsant
    Malinee, Rozita
    Sommaluan, Suchada
    Korkiatsakul, Veerawat
    Worawichawong, Suchin
    Rerkamnuaychoke, Budsaba
    Kongruang, Adcharee
    Aeesoa, Suraida
    Lertsithichai, Panuwat
    Kijvikai, Kittinut
    Kongchareonsombat, Wisoot
    Siriboonpiputtana, Teerapong
    PRACTICAL LABORATORY MEDICINE, 2024, 40
  • [2] Alterations of the cyclin-dependent kinase inhibitor genes CDKN2A, CDKN2B and CDKN2C in atypical and anaplastic meningiomas
    Boström, J
    Meyer-Puttlitz, B
    Blaschke, B
    Wolter, M
    Weber, RG
    Lichter, P
    Collins, VP
    Reifenberger, G
    BRAIN PATHOLOGY, 2000, 10 (04) : 742 - 742
  • [3] Fadraciclib, an oral CDK2/9 inhibitor, in patients with advanced solid tumors and lymphoma with CDKN2A and/or CDKN2B genetic alterations
    Piha-Paul, S.
    Garralda, E.
    Vieito, M.
    Oh, D. Y.
    Huang, J.
    Villalona-Calero, M.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S26 - S26
  • [4] Methylation patterns of the CDKN2B and CDKN2A genes in an indigenous population exposed to pesticides
    Paredes-Cespedes, Diana M.
    Bernal-Hernandez, Yael Yvette
    Herrera-Moreno, Jose Francisco
    Rojas-Garcia, Aurora Elizabeth
    Medina-Diaz, Irma Martha
    Gonzalez-Arias, Cyndia A.
    Barron-Vivanco, Briscia Socorro
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [5] Methylation patterns of the CDKN2B and CDKN2A genes in an indigenous population exposed to pesticides
    Paredes-Cespedes, Diana M.
    Bernal-Hernandez, Yael Yvette
    Herrera-Moreno, Jose Francisco
    Rojas-Garcia, Aurora Elizabeth
    Medina-Diaz, Irma Martha
    Gonzalez-Arias, Cyndia A.
    Barron-Vivanco, Briscia Socorro
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [6] Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
    José F Flores
    Pamela M Pollock
    Graeme J Walker
    J Michael Glendening
    Amy H-T Lin
    Jane M Palmer
    Marilyn K Walters
    Nicholas K Hayward
    Jane W Fountain
    Oncogene, 1997, 15 : 2999 - 3005
  • [7] Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
    Flores, JF
    Pollock, PM
    Walker, GJ
    Glendening, JM
    Lin, AHT
    Palmer, JM
    Walters, MK
    Hayward, NK
    Fountain, JW
    ONCOGENE, 1997, 15 (24) : 2999 - 3005
  • [8] Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma
    Iolascon, A
    Faienza, MF
    Coppola, B
    Rosolen, A
    Basso, G
    DellaRagione, F
    Schettini, F
    GENES CHROMOSOMES & CANCER, 1996, 15 (04): : 217 - 222
  • [9] Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma
    Iolascon, A
    Giordani, L
    Moretti, A
    Basso, G
    Borriello, A
    Della Ragione, F
    HEPATOLOGY, 1998, 27 (04) : 989 - 995
  • [10] Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans
    Lee, Ho-Su
    Lee, Soo Bin
    Kim, Byoung Mok
    Hong, Myunghee
    Jung, Seulgi
    Hong, Jeonghoon
    Baek, Jiwon
    Han, Buhm
    Oh, Seak Hee
    Kim, Kyung Mo
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Ye, Byong Duk
    Song, Kyuyoung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (04) : 887 - 893